David P. Schenkein

Companies

• Regeneron PharmaceuticalsBoard member Sep 12, 2023 to now¹
• Prime Medicine, Inc.Board member Oct 19, 2022 to now²
• Denali Therapeutics Inc.Board member Dec 7, 2017 to now³
• Agios PharmaceuticalsBoard member Jul 23, 2013 to Jun 24, 2024⁴
• bluebird bioBoard member Jun 18, 2013 to Jun 22, 2020⁵
• Agios PharmaceuticalsChief executive officer Jul 23, 2013 to Nov 19, 2018⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Agios Pharmaceuticals AGIO205,324 shares⁶$7.1M at $34.36Jun 17, 2024
• DTDenali Therapeutics Inc. DNLI52,897 shares⁷$965.4K at $18.25Jun 5, 2026
• Regeneron Pharmaceuticals REGN603 shares⁸$476.7K at $790.61Jan 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 3, 2026Granted 6,408 shares of Denali Therapeutics Inc.⁷
• Jan 2, 2026Granted 155 shares of Regeneron Pharmaceuticals⁸
• Jun 3, 2025Granted 6,037 shares of Denali Therapeutics Inc.⁹
• Jan 2, 2025Granted 166 shares of Regeneron Pharmaceuticals¹⁰
• Nov 11, 2024Sold 32,312 shares at $32.87 of Denali Therapeutics Inc.¹¹
• Nov 11, 2024Sold 27,129 shares at $32.09 of Denali Therapeutics Inc.¹¹
• Nov 11, 2024Exercised options 47,165 shares at $18.00 of Denali Therapeutics Inc.¹¹
• Jun 13, 2024Exercised options 3,388 shares of Agios Pharmaceuticals⁶
• May 31, 2024Granted 5,967 shares of Denali Therapeutics Inc.¹²
• Feb 27, 2024Sold 57,471 shares at $34.89 of Agios Pharmaceuticals¹³
• Feb 27, 2024Exercised options 57,471 shares at $31.64 of Agios Pharmaceuticals¹³
• Feb 27, 2024Sold 11,858 shares at $33.60 of Agios Pharmaceuticals¹³
• Feb 27, 2024Exercised options 11,858 shares at $31.64 of Agios Pharmaceuticals¹³
• Feb 26, 2024Sold 20,411 shares at $33.19 of Agios Pharmaceuticals¹⁴
• Feb 26, 2024Exercised options 20,411 shares at $31.64 of Agios Pharmaceuticals¹⁴
• Feb 23, 2024Sold 47,731 shares at $33.05 of Agios Pharmaceuticals¹⁴
• Feb 23, 2024Exercised options 47,731 shares at $31.64 of Agios Pharmaceuticals¹⁴
• Jan 2, 2024Granted 42 shares of Regeneron Pharmaceuticals¹⁵
• Sep 8, 2023Granted 240 shares of Regeneron Pharmaceuticals¹⁶
• Jun 21, 2023Exercised options 4,975 shares of Agios Pharmaceuticals¹⁷
• Jun 1, 2023Granted 4,216 shares of Denali Therapeutics Inc.¹⁸
• Apr 3, 2023Sold 16,363 shares at $22.85 of Agios Pharmaceuticals¹⁹
• Apr 3, 2023Exercised options 16,363 shares at $9.05 of Agios Pharmaceuticals¹⁹
• Mar 27, 2023Sold 20,000 shares at $22.15 of Agios Pharmaceuticals²⁰
• Mar 27, 2023Exercised options 20,000 shares at $9.05 of Agios Pharmaceuticals²⁰